Researchers examined whether polygenic scores for human longevity correspond to structural brain measures on MRI in a population-based cohort of 70-year-olds. The work tests whether inherited predisposition to exceptional lifespan is visible in the aging brain decades before survival outcomes are known, positioning neuroimaging as a possible intermediate marker of biological aging.
Key Points
- Longevity polygenic scores compared with brain MRI measures at age 70
- Population-based cohort design isolates genetic signal in midlife-to-late-life brain
- Neuroimaging tested as intermediate phenotype for inherited lifespan potential
Longevity Analysis
Genetic predisposition to long life is typically validated only at the end of life, which makes it useless as a guide for intervention. Linking longevity-associated variants to measurable brain structure converts a probabilistic score into something that can be observed, tracked, and potentially modified — brain volume and white matter integrity respond to vascular health, sleep quality, metabolic control, and sustained physical loading. Genetic risk sets a trajectory rather than an endpoint, and the practical value lies in identifying which structural signals merit closer surveillance and which daily inputs shape them over the following decades.
Original published by Nature - npj Aging, by Nazib M Seidu.

